MetLife: Poised for a turnaround

This insurer offers a powering and growing franchise at a depressed stock price.

By TheStockAdvisors Mar 13, 2013 10:51AM
Insurance NULL CorbisBy George Putnam, The Turnaround Letter

Founded in 1864 as the National Union Life and Limb Insurance Company, MetLife (MET) has grown into the largest life insurance company in the U.S. It currently has about $4.2 trillion of life insurance in force. MetLife has long had one of the strongest franchises and best recognized brands in the life insurance business.

The stock rose gradually to a high of $71 in 2007. Then, like many financial companies, MetLife saw its stock get hit hard in 2008, and it has never really recovered.

The company is now shedding other business lines so that it can focus more on its core competency.

For example, MetLife recently completed the sale of its banking business to GE. This not only removes the distraction of the banking business, but it also gets the company out from under the more stringent capital requirements that apply to bank holding companies.

The company is also shifting its business mix to improve its risk profile. One example of this is management's decision to move away from the capital intensive and market sensitive variable annuity business.

In addition to its strength in the U.S., MetLife has a substantial and growing presence abroad. It is particularly strong in emerging markets which are likely to offer much greater growth opportunities than the U.S. and Europe.

The company greatly boosted its global and emerging market exposure when it purchased AIG's ALICO unit in 2010. Despite the strength of the franchise, the stock looks cheap on a valuation basis as investors continue to spurn old line financial companies.

The stock currently trades at just 0.62 times book value, compared to well above 1.0 where it traded for many years before 2008. Moreover, the stock has a forward price-to-earnings ratio of only about 7.

While MetLife has extricated itself from bank holding company regulation, it is still subject to the non-bank Systematically Important Financial Institution rules created by the Dodd-Frank legislation. Since those rules are still evolving, the company has been cautious about buying back stock or increasing its dividend.

However, we expect MetLife to take one or both of those shareholder friendly steps once the regulatory fog begins to clear.

We believe that Wall Street's current aversion to financial stocks creates an opportunity to buy a powerful and growing insurance franchise at a depressed price. We recommend buying MetLife up to $45.

More from
Tags: MET


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

123 rated 1
262 rated 2
480 rated 3
651 rated 4
649 rated 5
629 rated 6
616 rated 7
496 rated 8
346 rated 9
111 rated 10

Top Picks

TAT&T Inc9



Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.